
|Videos|June 10, 2019
Dr. Chiara Cremolini on the Updated Results of the TRIBE2 Study for Unresectable Colorectal Cancer
Author(s)Chiara Cremolini, MD
Cancer Network spoke with Chiara Cremolini, MD, about the updated results of the phase III randomized strategy study TRIBE2, which looked at the first- and second-line treatment of unresectable metastatic colorectal cancer.
Advertisement
Cancer Network spoke with Chiara Cremolini, MD, of Azienda Ospedaliero-Universitaria Pisana, about the updated results of the phase III randomized strategy study TRIBE2, which looked at the first- and second-line treatment of unresectable metastatic colorectal cancer.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab Yields High pCR Rate in Desmoplastic Melanoma
2
New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma
3
Fecal Microbiota Transplantation Shows Feasibility in Metastatic RCC
4
Reducing Secondary Diagnostic Delay Through the Breast Clinical Reporting and Data System
5



































